Stockreport

Better Buy: Crispr Therapeutics vs. bluebird bio [The Motley Fool]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF bluebird bio(NASDAQ:BLUE 00Bluebird has also been outperformed by one of its competitors in the gene-editing industry, namelyCRISPR TherapeuticsNASDAQ:CRSPCRISPR Therape [Read more]